CSPC Innovation Pharmaceutical News and Activities

CSPC Innovation Pharmaceutical is a company listed under the stock ticker 300765 (CN).

View the org chart displaying its 10 main executives

Most searched biographies at CSPC Innovation Pharmaceutical

• Bing Yao, General Manager and Chairman of the Board
• Lei Cai, Director
• Jianping Zhou, Independent Director

Popular executive movements at CSPC Innovation Pharmaceutical

• Zhou Hong has joined the company as Independent Non-Executive Director  (posted on October 20 2025).

Create your alert
to follow the executive moves at CSPC Innovation Pharmaceutical.

CSPC Innovation Pharmaceutical has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by CSPC Innovation Pharmaceutical

Social media about CSPC Innovation Pharmaceutical

• CSPC Innovation Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• CSPC Innovation Pharmaceutical on LinkedIn, X (Twitter) & YouTube